Noventra Pharma TZ VIAL 30mg 
An agonist proven for weight loss, appetite suppression, fat loss & metabolic support. 
Description
Triggers insulin release and glucose regulation.
Appetite Suppression.
Slows gastric emptying and increases satiety, leading to reduced caloric intake.
Metabolic Enhancement
Improves insulin sensitivity and promotes fat oxidation for sustained weight loss.
A novel investigational medication designed to address the complex challenges of type 2 diabetes mellitus (T2DM). It represents an innovative approach to diabetes management, belonging to a class of drugs known as dual glucose-dependent insulinotropic peptide receptor agonists.
By targeting dual pathways simultaneously, it offers a multifaceted approach to glycemic control in individuals with T2DM.
TZ works by activating dual receptors, leading to increased insulin secretion, decreased glucagon release, slowed gastric emptying and reduced food intake. This comprehensive mechanism of action makes it a promising candidate for achieving and maintaining optimal blood sugar levels in patients with T2DM.
Clinical trials evaluating tirzepatide have demonstrated its efficacy in improving glycemic control, fasting plasma glucose levels and body weight. Additionally, it has shown a favorable safety profile, with side effects generally being well-tolerated.